Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002789334 | SCV003746810 | uncertain significance | Inborn genetic diseases | 2022-05-04 | criteria provided, single submitter | clinical testing | The c.5131C>T (p.L1711F) alteration is located in exon 15 (coding exon 15) of the TECTA gene. This alteration results from a C to T substitution at nucleotide position 5131, causing the leucine (L) at amino acid position 1711 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003720756 | SCV004507453 | likely benign | not provided | 2023-06-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003720756 | SCV005370768 | uncertain significance | not provided | 2023-07-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |